Financial insights of MRVI

MyFinsight

For the year ending 2025-12-31, MRVI made $185,743K in revenue. -$130,773K in net income. Net profit margin of -70.41%.

Income Statement	2025-12-31
Revenue	185,743
Cost of revenue	151,753
Gross profit	33,990
Selling, general and administrative	145,118
Research and development	17,402
Change in estimated fair value of contingent consideration	200
Impairment of goodwill and long-lived assets	68,709
Restructuring	17,827
Total operating expenses	249,256
Loss from operations	-215,266
Interest expense	26,992
Interest income	11,436
Loss on extinguishment of debt	0
Change in payable to related parties pursuant to the tax receivable agreement	0
Other expense	-4,152
(loss) income before income taxes	-234,974
Income tax (benefit) expense	-4,212
Net loss	-230,762
Net loss attributable to non-controlling interests	-99,989
Net loss attributable to maravai lifesciences holdings, inc	-130,773

Basic EPS	-0.9
Diluted EPS	-0.9
Basic Average Shares	144,360,000
Diluted Average Shares	144,360,000